About Us

/
Gardasil

Gardasil

/
Gardasil
Loading...

Gardasil

Category:
Composition: Human Papillomavirus Quadrivalent Vaccine
(Type 6,11,26 & 18) HPV

Description:

Gardasil is a vaccine designed to protect against infections caused by four types of Human Papillomavirus (HPV) – types 6, 11, 16, and 18. HPV types 16 and 18 are responsible for approximately 70% of cervical cancer cases, while types 6 and 11 cause about 90% of genital warts. Gardasil helps prevent cervical, vulvar, vaginal, and anal cancers, as well as genital warts in both males and females.

Gardasil stimulates the immune system to produce antibodies against HPV types 6, 11, 16, and 18, offering protection before exposure to the virus. It does not treat existing HPV infections or associated diseases but helps prevent new infections.

Loading...

Description

Dosage and Administration
  • Recommended for boys and girls starting from 9 years up to 26 years of age.
  • Administered intramuscularly in a series of two or three doses depending on the age at initial vaccination.
  • The second dose is typically given 1-2 months after the first, and the third dose about 6 months after the first.
  • Pain, swelling, and redness at the injection site
  • Fever
  • Headache
  • Nausea
  • Dizziness and fainting (especially in adolescents)
  • Severe allergic reactions
  • Syncope (temporary loss of consciousness)
  • Should not be administered to individuals with a history of severe allergic reactions to any component of the vaccine.
  • Vaccination should be delayed in individuals suffering from moderate or severe acute illnesses.
  • Patients should remain seated or lying down for 15 minutes after receiving the vaccine to prevent fainting-related injuries.
  • Gardasil does not substitute for routine cervical cancer screening.